Form 4: Edwards Lifesciences Executive Daniel J. Lippis Reports Stock Disposals to Cover Tax Obligations

Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, reported disposing of shares to cover tax obligations arising from vesting equity.

Summary

• On February 18, 2025, Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, filed a Form 4 with the SEC.
• The filing reports the disposal of common stock to cover tax obligations.
• Specifically, 214 shares were disposed of on February 16, 2025, 165 shares on February 17, 2025, and 222 shares on February 18, 2025, all at a price of $76.19 per share.
• Following these transactions, Lippis beneficially owns 22,588.0651 shares of Edwards Lifesciences common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock disposals for tax purposes, a routine financial activity.

Industry Context

Executive stock disposals for tax obligations are a common occurrence, particularly after equity awards vest. This filing provides transparency into the transactions of a key executive at Edwards Lifesciences.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small number of shares involved.

Key Dates

Keywords

Form 4, Edwards Lifesciences, Stock Disposal, Beneficial Ownership, Daniel J. Lippis, Tax Obligations, Equity Securities